Arsanis, Inc. License Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement, dated as of December 13, 2016, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Georgetown University
License Agreements
Arsanis, Inc.
Biotechnology
NY
2019
License Agreement, dated as of November 13, 2020, by and between X4 Pharmaceuticals Inc. and the Dana Farber Cancer Institute
License Agreements
Arsanis, Inc.
Biotechnology
MA
2021
Exclusive License Agreement, dated as of December 23, 2016, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Beth Israel Deaconess Medical Center
License Agreements
Arsanis, Inc.
Biotechnology
MA
2019
License Agreement, dated as of December 13, 2016, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Georgetown University
License Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Amendment No. 1 to License Agreement, dated as of October 23, 2014, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Genzyme Corporation, a Sanofi...
License Agreements
Arsanis, Inc.
Biotechnology
2019
License Agreement, dated as of July 10, 2014, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, LLC) and Genzyme Corp., a Sanofi company
License Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Exclusive License Agreement, dated as of December 23, 2016, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Beth Israel Deaconess Medical Center
License Agreements
Arsanis, Inc.
Biotechnology
MA
2019
Amendment No. 1 to License Agreement, dated as of October 23, 2014, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Genzyme Corporation, a Sanofi...
License Agreements
Arsanis, Inc.
Biotechnology
2019
License Agreement, dated as of July 10, 2014, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, LLC) and Genzyme Corp., a Sanofi company
License Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Amendment No. 1 to the Option and License Agreement, dated as of February 27, 2017, by and between the Registrant and Adimab, LLC, dated as of October 13, 2017
License Agreements
Arsanis, Inc.
Biotechnology
2017
Option and License Agreement, dated as of February 27, 2017, by and between the Registrant and Adimab, LLC
License Agreements
Arsanis, Inc.
Biotechnology
NY
2017